// App-Quantinova.ai

18892 : Clinical and Hemodynamic Factors Influence the Risk of Pulmonary Hypertension in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights from the PARTNER I Trial and Registry

Researchers

Presenter

  • Alan Zajarias

Principal Investigators

  • Hersh Maniar

  • Vinod H. Thourani

  • Pamela S. Douglas

  • Scott Lim

  • Martin B Leon

  • Michael J. Mack

  • Rakesh M Suri

  • D. Craig Miller

  • John Webb

  • Lars G Svensson

  • Ke Xu

  • Fay Lin

  • Shing-Chiu Wong

  • Vasilis Babaliaros

Medical Centers

  • Radiology, Washington Univ Sch of Medicine, Saint Louis, MO

  • Columbia University Medical Center, New York-Presbyterian Hospital, New York, NY

  • Mayo Clinic, Rochester, MN

  • Cardiovascular Research Foundation, Orangeburg, NY

  • Duke Univ Sch of Med & Duke Clinical Res Inst, Durham, NC

  • Emory University School of Medicine, Atlanta, GA

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • Emory University, Atlanta, GA

  • Stanford Univ, Palo Alto, CA

  • St Pauls Hospital, Vancouver, BC, Canada

  • Baylor Healthcare System, Dallas, TX

  • University of Virgina, Charlottesville, VA

  • Cleveland Clinic, Cleveland, OH

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

  • Aortic stenosis

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim